ask="6.50"
ask_size="100"
average_daily_volume="102927"
bid="N/A"
bid_size="N/A"
book_value="3.21"
change="+0.30"
change_from_200_day_moving_average="-2.88"
change_from_50_day_moving_average="0.53"
change_from_52_week_high="-11.40"
change_From_52_week_low="1.80"
change_in_percent="+5.00%"
close="6.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.49"
ebitda="-19.00M"
eps_estimate_current_year="-2.76"
eps_estimate_next_quarter="-0.72"
eps_estimate_next_year="-1.85"
ex_dividend_date="N/A"
float_shares="6447000"
high="6.30"
high_52_weeks="17.70"
last_trade_date="3/13/2017"
last_trade_price="6.30"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="5.95"
low_52_weeks="4.50"
market_capitalization="49.25M"
moving_average_200_day="9.18"
moving_average_50_day="5.77"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.64"
open="6.05"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-31.40%"
percent_change_from_50_day_moving_average="+9.27%"
percent_change_from_52_week_high="-64.41%"
percent_change_from_52_week_low="+40.00%"
previous_close="6.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.87"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="2.53"
stock_exchange="NCM"
symbol="TRIL"
volume="19943"
weeks_range_52="4.50 - 17.70"
